- WASHINGTON (Reuters) - U.S.
officials have approved OraSure Technologies Inc.'s OraQuick HIV test,
a blood test that delivers results in as little as 20 minutes, Health and
Human Service Secretary Tommy Thompson said on Thursday.
- "With this new test, in less than half an hour,
(patients) can learn preliminary information about their HIV status, allowing
them to get the care they need to slow the progression of their disease
and to take precautionary measures to help prevent the spread of this deadly
virus," he said.
- Abbott Laboratories Inc. has an agreement with OraSure
to help distribute the HIV test.
- Orasure's shares rose 66 cents to $6.44, or 11.25 percent
in midday trading on Nasdaq.
- Abbot's shares were down 5 cents to $45.50 on the New
York Stock Exchange.
- Copyright © 2002 Reuters Limited. All rights reserved.
Republication or redistribution of Reuters content is expressly prohibited
without the prior written consent of Reuters. Reuters shall not be liable
for any errors or delays in the content, or for any actions taken in reliance